Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

A cross-sectional study of elderly Asian and European women with primary operable breast cancer aged 70 and older. Are there differences?

Tea MK, Tang L, Di GH, Muin D, Steurer S, Delancey JW, Shao ZM, Singer CF.

Maturitas. 2012 Nov;73(3):251-4. doi: 10.1016/j.maturitas.2012.08.001.

PMID:
22951149
2.

Is breast cancer in young Asian women more aggressive than in Caucasians? A cross-sectional analysis.

Tea MK, Fan L, Delancey JW, Staudigl C, Steurer S, Lang C, Shao ZM, Singer CF.

Tumour Biol. 2013 Aug;34(4):2379-82. doi: 10.1007/s13277-013-0786-z.

PMID:
23584900
3.
4.

Clinicopathologic and prognostic characteristics of triple-negative breast cancer.

Tian XS, Cong MH, Zhou WH, Zhu J, Chen YZ, Liu Q.

Onkologie. 2008 Nov;31(11):610-4. doi: 10.1159/000162288.

PMID:
19145094
5.

Breast cancer in Chinese women younger than age 40: are they different from their older counterparts?

Kwong A, Cheung P, Chan S, Lau S.

World J Surg. 2008 Dec;32(12):2554-61. doi: 10.1007/s00268-008-9589-6.

PMID:
18408960
6.

Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.

Königsberg R, Pfeiler G, Klement T, Hammerschmid N, Brunner A, Zeillinger R, Singer C, Dittrich C.

Eur J Cancer. 2012 Nov;48(16):2962-8. doi: 10.1016/j.ejca.2012.04.019.

PMID:
22647688
7.

Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women.

Selvarajan S, Wong KY, Khoo KS, Bay BH, Tan PH.

Pathology. 2006 Dec;38(6):528-33.

PMID:
17393979
8.

Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.

Lund MJ, Butler EN, Hair BY, Ward KC, Andrews JH, Oprea-Ilies G, Bayakly AR, O'Regan RM, Vertino PM, Eley JW.

Cancer. 2010 Jun 1;116(11):2549-59. doi: 10.1002/cncr.25016.

9.

Survival rates of invasive breast cancer among ethnic Chinese women born in East Asia and the United States.

Chuang SC, Chen W, Hashibe M, Li G, Zhang ZF.

Asian Pac J Cancer Prev. 2006 Apr-Jun;7(2):221-6.

10.

Triple negative status is a poor prognostic indicator in Chinese women with breast cancer: a ten year review.

Ma KK, Chau WW, Wong CH, Wong K, Fung N, Lee AJ, Choi CL, Suen DT, Kwong A.

Asian Pac J Cancer Prev. 2012;13(5):2109-14.

11.

Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country.

Tan GH, Taib NA, Choo WY, Teo SH, Yip CH.

Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):395-8.

13.

[Characterization of hormone receptor status in 5758 Chinese females with breast cancer].

Gao JD, Wang J, Feng XL, Zhong YX, Wang X.

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):683-6. Chinese.

PMID:
20021865
14.

Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.

Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2009 May;115(2):325-33. doi: 10.1007/s10549-008-0096-0.

PMID:
18563552
17.

Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy.

Giuliani S, Leonardi E, Aldovini D, Bernardi D, Pellegrini M, Soli F, Ferro A, Dalla Palma P, Decarli N, Barbareschi M.

Pathologica. 2012 Jun;104(3):93-7.

PMID:
22931039
18.

Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.

Zhang J, Pei R, Pang Z, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y.

Breast Cancer Res Treat. 2012 Apr;132(2):421-8. doi: 10.1007/s10549-011-1596-x.

PMID:
21614564
19.

Factors associated with HER2 overexpression in breast cancer: Experience in an Asian developing country.

Tan GH, Choo WY, Taib NA, Yip CH.

Asian Pac J Cancer Prev. 2009;10(5):837-40.

20.

Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.

McBride R, Hershman D, Tsai WY, Jacobson JS, Grann V, Neugut AI.

Cancer. 2007 Sep 15;110(6):1201-8.

Items per page

Supplemental Content

Support Center